Particles from preformed polymers as carriers for drug delivery

EXCLI Journal

Volumn 13, Issue , 2014, Pages 28-57

  Miladi, K ^a,b,c   Ibraheem, D ^a,b   Iqbal, M ^a,b   Sfar, S ^c   Fessi, H ^a,b   Elaissari, A ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Carriers; Drug delivery; Encapsulation; Operating conditions; Particles; Polymer

Indexed keywords

EID: 84893271594     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Review

References (280)

1. Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. Naproxeneudragit rs100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces 2011;83:155-9.
2. Agnihotri SM, Vavia PR. Drug loaded poly[lac(glcleu)] microparticles: formulation and release characteristics. Colloids Surf B Biointerfaces 2009;74: 336-9.
3. Ahmad H. A special issue on polymer and hybrid particles for biomedical applications. J Colloid Sci Biotechnol 2013;2:153-4.
4. Al-Kassas R. Design and in vitro evaluation of gentamicin-eudragit microspheres intended for intraocular administration. J Microencapsul 2004;21:71-81.
5. Alhalaweh A, Andersson S, Velaga SP. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery. Eur J Pharm Sci 2009;38: 206-14.
6. Almouazen E, Bourgeois S, Boussaïd A, Valot P, Malleval C et al. Development of a nanoparticlebased system for the delivery of retinoic acid into macrophages. Int J Pharm 2012;430:207-15.
7. Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and dna delivery. Adv Drug Deliv Rev 2005;57:411-30.
8. Año G, Esquisabel A, Pastor M, Talavera A, Cedré B et al. A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated vibrio cholerae. Vaccine 2011;29:5758-64.
9. Argemí A, Vega A, Subra-Paternault P, Saurina J. Characterization of azacytidine/poly(l-lactic) acid particles prepared by supercritical antisolvent precipitation. J Pharm Biomed Anal 2009;50:847-52.
10. Arias JL, López-Viota M, Sáez-Fernández E, Ruiz MA. Formulation and physicochemical characterization of poly(e{open}-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium. Colloids Surf B Biointerfaces 2010;75:204-8.
11. Ariga K, Lvov YM, Kawakami K, Ji Q, Hill JP. Layer-by-layer self-assembled shells for drug delivery. Adv Drug Deliv Rev 2011;63:762-71.
12. Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Theophylline particle design using chitosan by the spray drying. Int J Pharm 2004; 270:167-74.
13. Asadi H, Rostamizadeh K, Salari D, Hamidi M. Preparation of biodegradable nanoparticles of triblock pla-peg-pla copolymer and determination of factors controlling the particle size using artificial neural network. J Microencapsul 2011;28:406-16.
14. Ataman-Önal Y, Munier S, Ganée A, Terrat C, Durand P-Y et al. Surfactant-free anionic pla nanoparticles coated with hiv-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 2006;112:175-85.
15. Aumelas A, Serrero A, Durand A, Dellacherie E, Leonard M. Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems. Colloids Surf B Biointerfaces 2007;59:74-80.
16. Avachat AM, Bornare PN, Dash RR. Sustained release microspheres of ropinirole hydrochloride: effect of process parameters. Acta Pharm Zagreb Croat 2011;61:363-76.
17. Avadi MR, Sadeghi AMM, Mohammadpour N, Abedin S, Atyabi F et al. Preparation and characterization of insulin nanoparticles using chitosan and arabic gum with ionic gelation method. Nanomed Nanotechnol Biol Med 2010;6:58-63.
18. Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 2005;26:2723-32.
19. Banerjee P, Deb J, Roy A, Ghosh A, Chakraborty P. Fabrication and development of pectin microsphere of metformin hydrochloride. ISRN Pharm 2012;230621. doi: 10.5402/2012/230621.
20. Baras B, Benoit M-A, Gillard J. Parameters influencing the antigen release from spray-dried poly(dllactide) microparticles. Int J Pharm 2000;200:133-45.
21. Basarkar A, Devineni D, Palaniappan R, Singh J. Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid dna. Int J Pharm 2007;343:247-54.
22. Bazylińska U, Lewińska A, Lamch L. Wilk KA. Polymeric nanocapsules and nanospheres for encapsulation and long sustained release of hydrophobic cyanine-type photosensitizer. Colloids Surf Physicochem Eng Asp 2013.
23. Beck-Broichsitter M, Ruppert C, Schmehl T, Guenther A, Betz T et al. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro. Nanomed Nanotechnol Biol Med 2011;7:341-50.
24. Beck-Broichsitter M, Schweiger C, Schmehl T, Gessler T, Seeger W, Kissel T. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. J Control Release 2012; 158:329-35.
25. Bege N, Renette T, Endres T, Beck-Broichsitter M, Hänggi D, Kissel T. In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm. Eur J Pharm Biopharm 2013;84:99-105.
26. Behera T, Swain P. Antigen adsorbed surface modified poly-e{open}-caprolactone microspheres stimulates both adaptive and innate immune response in fish. Vaccine 2012;30:5278-84.
27. Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly(epsiloncaprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999;184:73-84.
28. Bernkop-Schnürch A, Heinrich A, Greimel A. Development of a novel method for the preparation of submicron particles based on thiolated chitosan. Eur J Pharm Biopharm 2006;63:166-72.
29. Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005;24:67-75.
30. Billon A, Chabaud L, Gouyette A, Bouler J-M, Merle C. Vancomycin biodegradable poly(lactideco-glycolide) microparticles for bone implantation. influence of the formulation parameters on the size, morphology, drug loading and in vitro release. J Microencapsul 2005;22:841-52.
31. Bittner B, Mäder K, Kroll C, Borchert H-H, Kissel T. Tetracycline-hcl-loaded poly(dl-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of γ-irradiation on radical formation and polymer degradation. J Control Release 1999; 59:23-32.
32. Blacklock J, You Y-Z, Zhou Q-H, Mao G, Oupický D. Gene delivery in vitro and in vivo from bioreducible multilayered polyelectrolyte films of plasmid dna. Biomaterials 2009;30:939-50.
33. Bozkir A, Saka OM. Formulation and investigation of 5-fu nanoparticles with factorial design-based studies. Il Farm 2005;60:840-6.
34. Bruschi M, Cardoso ML, Lucchesi M, Gremião MP. Gelatin microparticles containing propolis obtained by spray-drying technique: preparation and characterization. Int J Pharm 2003;264:45-55.
35. Budhian A, Siegel SJ, Winey KI. Haloperidolloaded plga nanoparticles: systematic study of particle size and drug content. Int J Pharm 2007;336: 367-75.
36. Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology towards biomedical applications. Adv Drug Deliv Rev 2008; 60:299-327.
37. Cadete A, Figueiredo L, Lopes R, Calado CCR, Almeida AJ, Gonçalves LMD. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Eur J Pharm Sci 2012;45:451-8.
38. Cal K, Sollohub K. Spray drying technique. i: hardware and process parameters. J Pharm Sci 2010;99: 575-86.
39. Campos EVR, de Melo NFS, de Paula E, Rosa AH, Fraceto LF. Screening of conditions for the preparation of poly(-caprolactone) nanocapsules containing the local anesthetic articaine. J Colloid Sci Biotechnol 2013;2:106-11.
40. Castelli F, Conti B, Maccarrone DE, Conte U, Puglisi G. Comparative study of 'in vitro' release of anti-inflammatory drugs from polylactide-coglycolide microspheres. Int J Pharm 1998;176:85-98.
41. Cevher E, Orhan Z, Mülazimoǧlu L, Şensoy D, Alper M et al. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant staphylococcus aureus with prepared microspheres. Int J Pharm 2006;317:127-35.
42. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS Pharm Sci Tech 2005;6:E329-57.
43. Chawla JS, Amiji MM. Biodegradable poly(εcaprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127-38.
44. Chen A-Z, Zhao Z, Wang S-B, Li Y, Zhao C, Liu Y-G. A continuous ress process to prepare pla-peg-pla microparticles. J Supercrit Fluids 2011;59:92-7.
45. Chen Y, Lin X, Park H, Greever R. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomed Nanotechnol Biol Med 2009;5: 316-22.
46. Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release 2002;83:389-400.
47. Çirpanli Y, Bilensoy E, Lale Doǧan A, Çaliş S. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm Biopharm 2009; 73:82-9.
48. Cirpanli Y, Allard E, Passirani C, Bilensoy E, Lemaire L et al. Antitumoral activity of camptothecinloaded nanoparticles in 9l rat glioma model. Int J Pharm 2011;403:201-6.
49. Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in plga nanoparticles. J Control Release 2009;133:90-5.
50. Contado C, Vighi E, Dalpiaz A, Leo E. Influence of secondary preparative parameters and aging effects on plga particle size distribution: a sedimentation field flow fractionation investigation. Anal Bioanal Chem 2013;405:703-11.
51. Conti B, Bucolo C, Giannavola C, Puglisi G, Giunchedi P, Conte U. Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation. Eur J Pharm Sci 1997;5: 287-93.
52. Cruz L, Assumpção E, Andrade SF, Conrado DJ, Kulkamp IC et al. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats. Eur J Pharm Sci 2010;40: 441-7.
53. Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM. Preparation and characterization of poly(dl-lactideco-glycolide) nanoparticles for sirna delivery. Int J Pharm 2010;390:70-5.
54. Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P et al. High loading efficiency and sustained release of sirna encapsulated in plga nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm 2011;77:26-35.
55. D'Aurizio E, van Nostrum CF, van Steenbergen MJ, Sozio P, Siepmann F et al. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. Int J Pharm 2011;409:289-96.
56. Da Silva AA Jr, de Matos JR, Formariz TP, Rossanezi G, Scarpa MV et al. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. Int J Pharm 2009;368:45-55.
57. Dai C, Wang Y, Hou X. Preparation and protein adsorption of porous dextran microspheres. Carbohydr Polym 2012;87:2338-43.
58. Dai M, Xu X, Song J, Fu S, Gou M et al. Preparation of camptothecin-loaded pcec microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. Cancer Lett 2011;312:189-96.
59. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. Plga-based nanoparticles: an overview of biomedical applications. J Control Release 2012;161:505-22.
60. Das S, Suresh PK, Desmukh R. Design of eudragit rl 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomed Nanotechnol Biol Med 2010;6:318-23.
61. Dash TK, Konkimalla VB. Poly-j{cyrillic, ukrainian}-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release 2012;158: 15-33.
62. De Melo NFS, Campos EVR, de Paula E, Rosa AH, Fraceto LF. Factorial design and characterization studies for articaine hydrochloride loaded alginate/chitosan nanoparticles. J Colloid Sci Biotechnol 2013;2:146-52.
63. De Villiers MM, Otto DP, Strydom SJ, Lvov YM. Introduction to nanocoatings produced by layer-bylayer (lbl) self-assembly. Adv Drug Deliv Rev 2011; 63:701-15.
64. Delie F, Berton M, Allémann E, Gurny R. Comparison of two methods of encapsulation of an oligonucleotide into poly(d,l-lactic acid) particles. Int J Pharm 2001;214:25-30.
65. Derakhshandeh K, Fathi S. Role of chitosan nanoparticles in the oral absorption of gemcitabine. Int J Pharm 2012;437:172-7.
66. Devissaguet J-P, Fessi H, Puisieux F. Process for the preparaton of dispersible colloidal systems of a substance in the form of nanocapsules. US Patent 5049322, 1991.
67. Dhanaraju MD, Jayakumar R, Vamsadhara C. Influence of manufacturing parameters on development of contraceptive steroid loaded injectable microspheres. Chem Pharm Bull (Tokyo) 2004;52:976-9.
68. Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomed 2011;6:877-95.
69. Doan TVP, Couet W, Olivier JC. Formulation and in vitro characterization of inhalable rifampicin-loaded plga microspheres for sustained lung delivery. Int J Pharm 2011;414:112-7.
70. Dong Y, Feng SS. Methoxy poly(ethylene glycol) poly(lactide) (mpeg-pla) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25: 2843-9.
71. Dong Y, Feng SS. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (mpegpla) nanoparticles for small-molecule drug chemotherapy. Biomaterials 2007;28:4154-60.
72. Doustgani A, Farahani EV, Imani M, Doulabi AH. Dexamethasone sodium phosphate release from chitosan nanoparticles prepared by ionic gelation method. J Colloid Sci Biotechnol 2012;1:42-50.
73. Du W-L, Niu S-S, Xu Y-L, Xu Z-R, Fan C-L. Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions. Carbohydr Polym 2009;75:385-9.
74. Duchêne D. Cyclodextrins in targeting application to nanoparticles. Adv Drug Deliv Rev 1999;36:29-40.
75. Duchêne D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting: application to nanoparticles. Adv Drug Deliv Rev 1999;36:29-40.
76. Eidi H, Joubert O, Attik G, Duval RE, Bottin MC et al. Cytotoxicity assessment of heparin nanoparticles in nr8383 macrophages. Int J Pharm 2010;396:156-65.
77. nd ed. Boca Raton, FL: CRC Press, 2002.
78. Eley JG, Mathew P. Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles. J Microencapsul 2007; 24:225-34.
79. Elias H-G. An introduction to plastics. Weinheim: Wiley-VCH, 2003.
80. Elizondo E, Veciana J, Ventosa N. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids. Nanomedicine 2012;7:1391-1408.
81. Elmizadeh H, Khanmohammadi M, Ghasemi K, Hassanzadeh G, Nassiri-Asl M, Garmarudi AB. Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using box-behnken statistical design. J Pharm Biomed Anal 2013;80:141-6.
82. Esmaeili A, Saremnia B, Koohian A, Rezazadeh S. Mechanism of nanocapsules of matricaria recutita l. extract formation by the emulsion-diffusion process. Superlattices Microstruct 2011;50:340-9.
83. Esposito E, Cervellati F, Menegatti E, Nastruzzi C, Cortesi R. Spray dried eudragit microparticles as encapsulation devices for vitamin c. Int J Pharm 2002;242:329-34.
84. Essa S, Rabanel JM, Hildgen P. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (pla) based nanoparticles. Int J Pharm 2010;388:263-73.
85. Fàbregas A, Miñarro M, García-Montoya E, PérezLozano P, Carrillo C et al. Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan-tripolyphosphate nanoparticles. Int J Pharm 2013;446:199-204.
86. Falamarzian A, Lavasanifar A. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(e{open}caprolactone) based nano-carriers for the solubilization and delivery of amphotericin b. Colloids Surf B Biointerfaces 2010;81:313-20.
87. Falco N, Reverchon E, Della Porta G. Injectable plga/hydrocortisone formulation produced by continuous supercritical emulsion extraction. Int J Pharm 2013;441:589-97.
88. Florindo HF, Pandit S, Lacerda L, Gonçalves LMD, Alpar HO, Almeida AJ. The enhancement of the immune response against s. equi antigens through the intranasal administration of poly-e{open}-caprolactonebased nanoparticles. Biomaterials 2009;30:879-91.
89. Fonseca C, Simões S, Gaspar R. Paclitaxel-loaded plga nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 2002;83:273-86.
90. Fredriksen BN, Grip J. Plga/pla microand nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of atlantic salmon (salmo salar l.). Vaccine 2012;30: 656-67.
91. Gaignaux A, Réeff J, Siepmann F, Siepmann J, De Vriese C et al. Development and evaluation of sustained-release clonidine-loaded plga microparticles. Int J Pharm 2012;437:20-8.
92. Galindo-Rodríguez SA, Puel F, Briançon S, Allémann E, Doelker E, Fessi H. Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci 2005;25:357-67.
93. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-tpp nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005;44:65-73.
94. Gander B, Johansen P, Nam-Trân H, Merkle HP. Thermodynamic approach to protein microencapsulation into poly(d,l-lactide) by spray drying. Int J Pharm 1996;129:51-61.
95. Garekani HA, Moghaddam ZF, Sadeghi F. Organic solution versus aqueous dispersion of eudragit rs in preparation of sustained release microparticles of theophylline using spray drying. Colloids Surf B Biointerfaces 2013;108:374-9.
96. Gennes P-G. Scaling concepts in polymer physics. Ithaca, NY: Cornell University Press, 197.
97. Gèze A, Aous S, Baussanne I, Putaux J, Defaye J, Wouessidjewe D. Influence of chemical structure of amphiphilic β-cyclodextrins on their ability to form stable nanoparticles. Int J Pharm 2002;242:301-5.
98. Giri TK, Choudhary C, Ajazuddin, Alexander A, Badwaik H, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J 2013;21:125-41.
99. Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm 2002;53: 233-9.
100. Gou M, Zheng L, Peng X, Men K, Zheng X et al. Poly(e{open}-caprolactone)-poly(ethylene glycol)-poly(e{open}caprolactone) (pcl-peg-pcl) nanoparticles for honokiol delivery in vitro. Int J Pharm 2009;375: 170-6.
101. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. Plga nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171-85.
102. Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S et al. Defining the drug incorporation properties of pla-peg nanoparticles. Int J Pharm 2000;199: 95-110.
103. Guenet J-M. Thermoreversible gelation of polymers and biopolymers. New York: Academic Press, 1992.
104. Guerreiro LH, Da Silva D, Ricci-Junior E, GirardDias W, Mascarenhas CM et al. Polymeric particles for the controlled release of human amylin. Colloids Surf B Biointerfaces 2012;94:101-6.
105. Gupta AP, Kumar V. New emerging trends in synthetic biodegradable polymers polylactide: a critique. Eur Polym J 2007;43:4053-74.
106. 1, a pulmonary selective vasodilator. Int J Pharm 2011;413:51-62.
107. Gyulai G, Pénzes CB, Mohai M, Csempesz F, Kiss É. Influence of surface properties of polymeric nanoparticles on their membrane affinity. Eur Polym J 2013;49:2495-503.
108. Hachicha W, Kodjikian L, Fessi H. Preparation of vancomycin microparticles: importance of preparation parameters. Int J Pharm 2006;324:176-84.
109. Han S, Li M, Liu X, Gao H, Wu Y. Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery. Colloids Surf B Biointerfaces 2013;102:833-41.
110. Hao S, Wang B, Wang Y, Zhu L, Wang B, Guo T. Preparation of eudragit l 100-55 enteric nanoparticles by a novel emulsion diffusion method. Colloids Surf B Biointerfaces 2013;108:127-33.
111. Haznedar S, Dortunç B. Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide. Int J Pharm 2004;269:131-40.
112. He P, Davis SS, Illum L. Chitosan microspheres prepared by spray drying. Int J Pharm 1999;187:53-65.
113. He C, Yin L, Tang C, Yin C. Multifunctional polymeric nanoparticles for oral delivery of tnf-α sirna to macrophages. Biomaterials 2013;34:2843-54.
114. Hegazy N, Demirel M, Yazan Y. Preparation and in vitro evaluation of pyridostigmine bromide microparticles. Int J Pharm 2002;242:171-4.
115. Hernán Pérez de la Ossa D, Ligresti A, Gil-Alegre ME, Aberturas MR, Molpeceres J et al. Poly-εcaprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy. J Control Release 2012;161:927-32.
116. Hombreiro Pérez M, Zinutti C, Lamprecht A, Ubrich N, Astier A et al. The preparation and evaluation of poly(∈caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release 2000;65:429-38.
117. Hu Y, Jiang X, Ding Y, Zhang L, Yang C et al. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 2003;24:2395-404.
118. Huang Y-Y, Chung T-W, Tzeng T. Drug release from pla/peg microparticulates. Int J Pharm 1997; 156:9-15.
119. Huang Y, Gao H, Gou M, Ye H, Liu Y et al. Acute toxicity and genotoxicity studies on poly(e{open}caprolactone)-poly(ethylene glycol)-poly(e{open}-caprolactone) nanomaterials. Mutat Res Toxicol Environ Mutagen 2010;696:101-6.
120. Hyvönen S, Peltonen L, Karjalainen M, Hirvonen J. Effect of nanoprecipitation on the physicochemical properties of low molecular weight poly(l-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionate. Int J Pharm 2005; 295:269-81.
121. Iler RK. Multilayers of colloidal particles. J Colloid Interface Sci 1966;21:569-94.
122. Illum L, Fisher AN, Jabbal-Gill I, Davis SS. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm 2001;222: 109-19.
123. Ishihara T, Takahashi M, Higaki M, Mizushima Y, Mizushima T. Preparation and characterization of a nanoparticulate formulation composed of peg-pla and pla as anti-inflammatory agents. Int J Pharm 2010;385:170-5.
124. Jafarinejad S, Gilani K, Moazeni E, Ghazi-Khansari M, Najafabadi AR, Mohajel N. Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation. Powder Technol 2012;222:65-70.
125. Jain AK, Swarnakar NK, Godugu C, Singh RP, Jain S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 2011;32:503-15.
126. Javadzadeh Y, Ahadi F, Davaran S, Mohammadi G, Sabzevari A, Adibkia K. Preparation and physicochemical characterization of naproxen-plga nanoparticles. Colloids Surf B Biointerfaces 2010;81:498-502.
127. Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L. Sustained release hgh microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. J Control Release 2010;141:153-60.
128. Kadam RS, Tyagi P, Edelhauser HF, Kompella UB. Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm 2012;434:140-7.
129. Kalani M, Yunus R. Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method. Int J Nanomed 2012;7:2165-72.
130. Kang Y, Wu J, Yin G, Huang Z, Yao Y et al. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded plla/plga microparticles using supercritical co2 technique. Eur J Pharm Biopharm 2008;70:85-97.
131. Kang Y, Yang C, Ouyang P, Yin G, Huang Z et al. The preparation of bsa-plla microparticles in a batch supercritical anti-solvent process. Carbohydr Polym 2009;77:244-9.
132. Kanthamneni N, Sharma S, Meenach SA, Billet B, Zhao J-C et al. Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions. Int J Pharm 2012;431:101-10.
133. Karataş A, Sonakin O, Kiliçarslan M, Baykara T. Poly (epsilon-caprolactone) microparticles containing levobunolol hcl prepared by a multiple emulsion (w/o/w) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics. J Microencapsul 2009;26:63-74.
134. Karnchanajindanun J, Srisa-ard M, Baimark Y. Genipin-cross-linked chitosan microspheres prepared by a water-in-oil emulsion solvent diffusion method for protein delivery. Carbohydr Polym 2011;85:674-80.
135. Katara R, Majumdar DK. Eudragit rl 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids Surf B Biointerfaces 2013;103:455-62.
136. Katare YK, Muthukumaran T, Panda AK. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded pla microparticles. Int J Pharm 2005;301:149-60.
137. Kauffman KJ, Kanthamneni N, Meenach SA, Pierson BC, Bachelder EM, Ainslie KM. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression. Int J Pharm 2012;422: 356-63.
138. Keegan GM, Smart JD, Ingram MJ, Barnes L-M, Burnett GR, Rees GD. Chitosan microparticles for the controlled delivery of fluoride. J Dent 2012;40: 229-40.
139. Khaled KA, Sarhan HA, Ibrahim MA, Ali AH, Naguib YW. Prednisolone-loaded plga microspheres. in vitro characterization and in vivo application in adjuvant-induced arthritis in mice. AAPS Pharm Sci Tech 2010;11:859-69.
140. Khalil NM, do Nascimento TCF, Casa DM, Dalmolin LF, de Mattos AC et al. Pharmacokinetics of curcumin-loaded plga and plga-peg blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 2013;101:353-60.
141. Khalil SKH, El-Feky GS, El-Banna ST, Khalil WA. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr Polym 2012;90:1244-53.
142. Khan MS, Vishakante GD, Bathool A. Development and characterization of brimonidine tartrate loaded eudragit nanosuspensions for ocular drug delivery. J Colloid Sci Biotechnol 2012;1:122-8.
143. Khayata N, Abdelwahed W, Chehna MF, Charcosset C, Fessi H. Preparation of vitamin e loaded nanocapsules by the nanoprecipitation method: from laboratory scale to large scale using a membrane contactor. Int J Pharm 2012;423:419-27.
144. Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-g in double emulsion. Eur J Med Chem 2009;44:2392-9.
145. Khoee S, Sattari A, Atyabi F. Physico-chemical properties investigation of cisplatin loaded polybutyladipate (pba) nanoparticles prepared by w/o/w. Mater Sci Eng C 2012;32:1078-86.
146. Konecsni K, Low NH, Nickerson MT. Chitosantripolyphosphate submicron particles as the carrier of entrapped rutin. Food Chem 2012;134:1775-9.
147. Koten JW, Van Luyn MJA, Cadée JA, Brouwer L, Hennink WE et al. Il-2 loaded dextran microspheres with attractive histocompatibility properties for local il-2 cancer therapy. Cytokine 2003;24:57-66.
148. Krishnakumar N, Sulfikkarali N, Rajendra Prasad N, Karthikeyan S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (hela) cancer cells. Biomed Prev Nutr 2011;1:223-31.
149. Kumar A, Gupta GK, Khedgikar V, Gautam J, Kushwaha P et al. In vivo efficacy studies of layerby-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model. Eur J Pharm Biopharm 2012; 82:508-17.
150. Kumari A, Yadav SK, Pakade YB, Kumar V, Singh B et al. Nanoencapsulation and characterization of albizia chinensis isolated antioxidant quercitrin on pla nanoparticles. Colloids Surf B Biointerfaces 2011;82:224-32.
151. Kwon H-Y, Lee J-Y, Choi S-W, Jang Y, Kim J-H. Preparation of plga nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf Physicochem Eng Asp 2001;182:123-30.
152. Labruère R, Sicard R, Cormier R, Turos E, West L. Poly(vinyl benzoate) nanoparticles for molecular delivery: studies on their preparation and in vitro properties. J Control Release 2010;148:234-40.
153. Lamalle-Bernard D, Munier S, Compagnon C, Charles M-H, Kalyanaraman VS et al. Coadsorption of hiv-1 p24 and gp120 proteins to surfactant-free anionic pla nanoparticles preserves antigenicity and immunogenicity. J Control Release 2006;115:57-67.
154. Le Ray A-M, Chiffoleau S, Iooss P, Grimandi G, Gouyette A et al. Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 2003;24:443-9.
155. Lee SJ, Hong G-Y, Jeong Y-I, Kang M-S, Oh J-S et al. Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity. Int J Pharm 2012;433:121-8.
156. Lemos-Senna E, Wouessidjewe D, Duchêne D, Lesieur S. Amphiphilic cyclodextrin nanospheres: particle solubilization and reconstitution by the action of a non-ionic detergent. Colloids Surf B Biointerfaces 1998;10:291-301.
157. Leo E, Forni F, Bernabei MT. Surface drug removal from ibuprofen-loaded pla microspheres. Int J Pharm 2000;196:1-9.
158. Li B, Wang Q, Wang X, Wang C, Jiang X. Preparation, drug release and cellular uptake of doxorubicin-loaded dextran-b-poly(e{open}-caprolactone) nanoparticles. Carbohydr Polym 2013;93:430-7.
159. Li P, Wang Y, Peng Z, She F, Kong L. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydr Polym 2011;85:698-704.
160. Li X, Chang S, Du G, Li Y, Gong J et al. Encapsulation of azithromycin into polymeric microspheres by reduced pressure-solvent evaporation method. Int J Pharm 2012;433:79-88.
161. Liang D, Fu X, Liao M, Yuan W, Su J. Development of dextran microparticles loaded with il-1ra of highencapsulation efficiency and high-bioactivity by a novel method without exposing il-1ra to water-oil interfaces. Powder Technol 2013;235:299-302.
162. Limayem Blouza I, Charcosset C, Sfar S, Fessi H. Preparation and characterization of spironolactoneloaded nanocapsules for paediatric use. Int J Pharm 2006;325:124-31.
163. Lince F, Marchisio DL, Barresi AA. Strategies to control the particle size distribution of poly-εcaprolactone nanoparticles for pharmaceutical applications. J Colloid Interface Sci 2008;322:505-15.
164. Ma J, Feng P, Ye C, Wang Y, Fan Y. An improved interfacial coacervation technique to fabricate biodegradable nanocapsules of an aqueous peptide solution from polylactide and its block copolymers with poly(ethylene glycol). Colloid Polym Sci 2001;279: 387-92.
165. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 2011;9:55.
166. Manchanda R, Fernandez-Fernandez A, Nagesetti A, McGoron AJ. Preparation and characterization of a polymeric (plga) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Colloids Surf B Biointerfaces 2010;75:260-7.
167. Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of dna and sirna. Adv Drug Deliv Rev 2010;62:12-27.
168. Martin TM, Bandi N, Shulz R, Roberts CB, Kompella UB. Preparation of budesonide and budesonide-pla microparticles using supercritical fluid precipitation technology. AAPS Pharm Sci Tech 2002;3:E18.
169. Martín-Banderas L, Alvarez-Fuentes J, DuránLobato M, Prados J, Melguizo C, FernándezArévalo M et al. Cannabinoid derivate-loaded plga nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomed 2012;7:5793-806.
170. Masson V, Maurin F, Fessi H, Devissaguet JP. Influence of sterilization processes on poly(εcaprolactone) nanospheres. Biomaterials 1997;18: 327-35.
171. Maya S, Kumar LG, Sarmento B, Sanoj Rejinold N, Menon D et al. Cetuximab conjugated o-carboxymethyl chitosan nanoparticles for targeting egfr overexpressing cancer cells. Carbohydr Polym 2013; 93:661-9.
172. Mazzaferro S, Bouchemal K, Maksimenko A, Skanji R, Opolon P, Ponchel G. Reduced intestinal toxicity of docetaxel loaded into mucoadhesive nanoparticles, in mouse xenograft model. J Colloid Sci Biotechnol 2012;1:210-7.
173. Mazzarino L, Travelet C, Ortega-Murillo S, Otsuka I, Pignot-Paintrand I et al. Elaboration of chitosancoated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci 2012;370:58-66.
174. Mehvar R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Release 2000;69:1-25.
175. Memişoǧlu E, Bochot A, Şen M, Duchêne D, Hincal AA. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. Int J Pharm 2003;251:143-53.
176. Menei P, Montero-Menei C, Venier M-C, Benoit J-P. Drug delivery into the brain using poly(lactideco-glycolide) microspheres. Expert Opin Drug Deliv 2005;2:363-76.
177. Miladi K, Sfar S, Fessi H, Elaissari A. Drug carriers in osteoporosis: preparation, drug encapsulation and applications. Int J Pharm 2013;445:181-95.
178. Minost A, Delaveau J, Bolzinger M-A, Fessi H, Elaissari A. Nanoparticles via nanoprecipitation process. Recent Pat Drug Deliv Formul 2012;6:250-8.
179. Miyazaki Y, Onuki Y, Yakou S, Takayama K. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process. Int J Pharm 2006;324:144-51.
180. Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X. Preparation and characterization of teniposide plga nanoparticles and their uptake in human glioblastoma u87mg cells. Int J Pharm 2012;436:815-24.
181. Mohajel N, Najafabadi AR, Azadmanesh K, Vatanara A, Moazeni E et al. Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex. Int J Pharm 2012; 423:577-85.
182. Mora-Huertas CE, Fessi H, Elaissari A. Polymerbased nanocapsules for drug delivery. Int J Pharm 2010;385:113-42.
183. Mora-Huertas CE, Garrigues O, Fessi H, Elaissari A. Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study. Eur J Pharm Biopharm 2012;80:235-9.
184. Morales-Cruz M, Flores-Fernández GM, MoralesCruz M, Orellano EA, Rodriguez-Martinez JA et al. Two-step nanoprecipitation for the production of protein-loaded plga nanospheres. Results Pharma Sci 2012;2:79-85.
185. Mu L, Feng S. Fabrication, characterization and in vitro release of paclitaxel (taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Release 2001;76:239-54.
186. Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci 2007;32:140-50.
187. Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin b-loaded gelatin nanoparticles. Nanomed Nanotechnol Biol Med 2008;4:252-61.
188. Nehilla B, Bergkvist M, Popat K, Desai T. Purified and surfactant-free coenzyme q10-loaded biodegradable nanoparticles. Int J Pharm 2008;348:107-14.
189. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997;28:25-42.
190. Osman R, Kan PL, Awad G, Mortada N, El-Shamy A-E, Alpar O. Enhanced properties of discrete pulmonary deoxyribonuclease i (dnasei) loaded plga nanoparticles during encapsulation and activity determination. Int J Pharm 2011;408:257-65.
191. Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex. Int J Pharm 2013;440:273-82.
192. Pariot N, Edwards-Lévy F, Andry M-C, Lévy M-C. Cross-linked β-cyclodextrin microcapsules. ii. retarding effect on drug release through semipermeable membranes. Int J Pharm 2002;232:175-81.
193. Park JH, Saravanakumar G, Kim K, Kwon IC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 2010;62: 28-41.
194. Patil SB, Sawant KK. Chitosan microspheres as a delivery system for nasal insufflation. Colloids Surf B Biointerfaces 2011;84:384-9.
195. Péan JM, Venier-Julienne MC, Boury F, Menei P, Denizot B, Benoit JP. Ngf release from poly(d,llactide-co-glycolide) microspheres. effect of some formulation parameters on encapsulated ngf stability. J Control Release 1998;56:175-87.
196. Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit rs100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002;16:53-61.
197. Pillai O, Panchagnula R. Polymers in drug delivery. Curr Opin Chem Biol 2001;5:447-51.
198. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation i. methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2006;2:8-21.
199. Poletto FS, Fiel LA, Donida B, Ré MI, Guterres SS, Pohlmann AR. Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent. Colloids Surf Physicochem Eng Asp 2008;324:105-12.
200. Powell TJ, Palath N, DeRome ME, Tang J, Jacobs A, Boyd JG. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective t-cell and antibody responses in vivo. Vaccine 2011;29:558-69.
201. Prata AS, Garcia L, Tonon RV, Hubinger MD. Wall material selection for encapsulation by spray drying. J Colloid Sci Biotechnol 2013;2:86-92.
202. Prior S, Gamazo C, Irache J, Merkle H, Gander B. Gentamicin encapsulation in pla/plga microspheres in view of treating brucella infections. Int J Pharm 2000;196:115-25.
203. Qi W, Yan X, Fei J, Wang A, Cui Y, Li J. Triggered release of insulin from glucose-sensitive enzyme multilayer shells. Biomaterials 2009;30:2799-806.
204. Quintanar-Guerrero D, Fessi H, Allémann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 1996;143:133-41.
205. Radtchenko IL, Sukhorukov GB, Möhwald H. Incorporation of macromolecules into polyelectrolyte micro and nanocapsules via surface controlled precipitation on colloidal particles. Colloids Surf Physicochem Eng Asp 2002;202:127-33.
206. Raffin RP, Colomé LM, Schapoval EES, Pohlmann AR, Guterres SS. Increasing sodium pantoprazole photostability by microencapsulation: effect of the polymer and the preparation technique. Eur J Pharm Biopharm 2008;69:1014-8.
207. Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 2011;36:887-913.
208. Rattes ALR, Oliveira WP. Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles. Powder Technol 2007;171:7-14.
209. Raval JP, Naik DR, Amin KA, Patel PS. Controlledrelease and antibacterial studies of doxycyclineloaded poly(ε-caprolactone) microspheres. J Saudi Chem Soc, 2011, epub ahead of print, http://dx.doi.org/10.1016/j.jscs.2011.11.004
210. Rawat A, Burgess DJ. Effect of ethanol as a processing co-solvent on the plga microsphere characteristics. Int J Pharm 2010;394:99-105.
211. Rees DA, Welsh EJ. Secondary and tertiary structure of polysaccharides in solutions and gels. Angew Chem Int Ed Engl 1977;16:214-24.
212. Rosset V, Ahmed N, Zaanoun I, Stella B, Fessi H, Elaissari A. Elaboration of argan oil nanocapsules containing naproxen for cosmetic and transdermal local application. J Colloid Sci Biotechnol 2012;1: 218-24.
213. Ruan G, Feng S-S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (pla-peg-pla) microspheres for controlled release of paclitaxel. Biomaterials 2003;24:5037-44.
214. Sacchetin PSC, Morales AR, Moraes ÂM, Rosa P de TV e. Formation of pla particles incorporating 17α-methyltestosterone by supercritical fluid technology. J Supercrit Fluids 2013;77:52-62.
215. Sajadi Tabassi SA, Tafaghodi M, Jaafari MR. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres. Int J Pharm 2008;360:12-7.
216. Sane A, Limtrakul J. Formation of retinyl palmitateloaded poly(l-lactide) nanoparticles using rapid expansion of supercritical solutions into liquid solvents (resolv). J Supercrit Fluids 2009;51:230-7.
217. Sanli D, Bozbag SE, Erkey C. Synthesis of nanostructured materials using supercritical co2: part i. physical transformations. J Mater Sci 2012;47: 2995-3025.
218. Santos DT, Albarelli JQ, Beppu MM, Meireles MAA. Stabilization of anthocyanin extract from jabuticaba skins by encapsulation using supercritical co2 as solvent. Food Res Int 2013;50:617-24.
219. Sastre RL, Olmo R, Teijón C, Muñíz E, Teijón JM, Blanco MD. 5-fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d,llactide) and poly(d,l-lactide-co-glycolide) polymers. Int J Pharm 2007;338:180-90.
220. Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded plga nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 2011;7:4169-76.
221. Seo D-H, Jeong Y-I, Kim D-G, Jang M-J, Jang MK, Nah J-W. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol) grafted chitosan. Colloids Surf B Biointerfaces 2009;69:157-63.
222. Seremeta KP, Chiappetta DA, Sosnik A. Poly(εcaprolactone), eudragit® rs 100 and poly(ε-caprolactone)/eudragit® rs 100 blend submicron particles for the sustained release of the antiretroviral efavirenz. Colloids Surf B Biointerfaces 2013;102:441-9.
223. Shao Y, Zhu B, Li J, Liu X, Tan X, Yang X. Novel chitosan microsphere-templated microcapsules suitable for spontaneous loading of heparin. Mater Sci Eng C 2009;29:936-41.
224. Silva AL, Rosalia RA, Sazak A, Carstens MG, Ossendorp F et al. Optimization of encapsulation of a synthetic long peptide in plga nanoparticles: lowburst release is crucial for efficient cd8(+) t cell activation. Eur J Pharm Biopharm 2013;83:338-45.
225. Simşek S, Eroǧlu H, Kurum B, Ulubayram K. Brain targeting of atorvastatin loaded amphiphilic plga-bpeg nanoparticles. J Microencapsul 2013;30:10-20.
226. Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'Hagan DT. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 2004;4:483-91.
227. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004;278:1-23.
228. Siqueira-Moura MP, Primo FL, Espreafico EM, Tedesco AC. Development, characterization, and photocytotoxicity assessment on human melanoma of chloroaluminum phthalocyanine nanocapsules. Mater Sci Eng C 2013;33:1744-52.
229. Soares ASP. A special issue on applications of microencapsulation. J Colloid Sci Biotechnol 2013;2:77.
230. Sollohub K, Cal K. Spray drying technique: ii. current applications in pharmaceutical technology. J Pharm Sci 2010;99:587-97.
231. Song KC, Lee HS, Choung IY, Cho KI, Ahn Y, Choi EJ. The effect of type of organic phase solvents on the particle size of poly(d,l-lactide-co-glycolide) nanoparticles. Colloids Surf Physicochem Eng Asp 2006;276:162-7.
232. Song X, Zhao Y, Wu W, Bi Y, Cai Z et al. Plga nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm 2008;350:320-9.
233. Sou T, Meeusen EN, de Veer M, Morton DAV, Kaminskas LM, McIntosh MP. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol 2011;29:191-8.
234. Souguir H, Salaün F, Douillet P, Vroman I, Chatterjee S. Nanoencapsulation of curcumin in polyurethane and polyurea shells by an emulsion diffusion method. Chem Eng J 2013;221:133-45.
235. Stulzer HK, Tagliari MP, Parize AL, Silva MAS, Laranjeira MCM. Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying. Mater Sci Eng C 2009;29:387-92.
236. Su Z, Sun F, Shi Y, Jiang C, Meng Q et al. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(d,llactide-co-glycolide) microsphere. Chem Pharm Bull (Tokyo) 2009;57:1251-6.
237. Sukhorukov GB, Donath E, Lichtenfeld H, Knippel E, Knippel M et al. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloids Surf Physicochem Eng Asp 1998;137:253-66.
238. Suksiriworapong J, Sripha K, Kreuter J, Junyaprasert VB. Functionalized (poly(e{open}-caprolactone))2-poly(ethyleneglycol) nanoparticles with grafting nicotinic acid as drug carriers. Int J Pharm 2012;423:562-70.
239. Surassmo S, Min S-G, Bejrapha P, Choi M-J. Effects of surfactants on the physical properties of capsicum oleoresin-loaded nanocapsules formulated through the emulsion-diffusion method. Food Res Int 2010;43:8-17.
240. Tawfeek HM. Evaluation of peg and mpeg-co-(pgaco-pdl) microparticles loaded with sodium diclofenac. Saudi Pharm J 2013;21:387-97.
241. Tewa-Tagne P, Briançon S, Fessi H. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics. Int J Pharm 2006;325:63-74.
242. Thomas C, Gupta V, Ahsan F. Influence of surface charge of plga particles of recombinant hepatitis b surface antigen in enhancing systemic and mucosal immune responses. Int J Pharm 2009;379:41-50.
243. Trapani A, Laquintana V, Denora N, Lopedota A, Cutrignelli A et al. Eudragit rs 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Eur J Pharm Sci 2007; 30:64-74.
244. Tse MT, Blatchford C, Oya Alpar H. Evaluation of different buffers on plasmid dna encapsulation into plga microparticles. Int J Pharm 2009;370:33-40.
245. Valot P, Baba M, Nedelec J-M, Sintes-Zydowicz N. Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules. Int J Pharm 2009;369:53-63.
246. Van de Ven H, Vermeersch M, Matheeussen A, Vandervoort J, Weyenberg W et al. Plga nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation. Int J Pharm 2011;420:122-32.
247. Van de Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P et al. Plga nanoparticles and nanosuspensions with amphotericin b: potent in vitro and in vivo alternatives to fungizone and ambisome. J Control Release 2012;161:795-803.
248. Van der Graaf S, Schroën CGPH, Boom RM. Preparation of double emulsions by membrane emulsification-a review. J Membr Sci 2005;251:7-15.
249. Vanderhoff JW, El-Aasser MS, Ugelstad J. Polymer emulsification process. U.S. Patent 4,177,177, December 1979.
250. Vandervoort J, Ludwig A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm 2004;57: 251-61.
251. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26:1025-58.
252. Vergaro V, Scarlino F, Bellomo C, Rinaldi R, Vergara D et al. Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells. Adv Drug Deliv Rev 2011;63:847-64.
253. Vila A, Gill H, McCallion O, Alonso MJ. Transport of pla-peg particles across the nasal mucosa: effect of particle size and peg coating density. J Control Release 2004;98:231-44.
254. Vila A, Sánchez A, Évora C, Soriano I, McCallion O, Alonso MJ. Pla-peg particles as nasal protein carriers: the influence of the particle size. Int J Pharm 2005;292:43-52.
255. Vladisavljević GT, Williams RA. Recent developments in manufacturing particulate products from double-emulsion templates using membrane and microfluidic devices. In: Aserin A (ed.): Multiple emulsions: technology and applications (pp 121-64). New York: Wiley, 2008.
256. Wang F-J, Wang C-H. Sustained release of etanidazole from spray dried microspheres prepared by nonhalogenated solvents. J Control Release 2002;81: 263-80.
257. Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS. Controlled preparation and antitumor efficacy of vitamin e tpgs-functionalized plga nanoparticles for delivery of paclitaxel. Int J Pharm 2013;446:24-33.
258. Wang S, Guo S, Cheng L. Disodium norcantharidate loaded poly(e{open}-caprolactone) microspheres: i. preparation and evaluation. Int J Pharm 2008;350:130-7.
259. Xie H, Smith JW. Fabrication of plga nanoparticles with a fluidic nanoprecipitation system. J Nanobiotechnol 2010;8:18.
260. Xin H, Chen L, Gu J, Ren X, Wei Z, et al. Enhanced anti-glioblastoma efficacy by ptx-loaded pegylated poly(e{open}-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int J Pharm 2010;402:238-47.
261. Yadav KS, Sawant KK. Formulation optimization of etoposide loaded plga nanoparticles by double factorial design and their evaluation. Curr Drug Deliv 2010;7:51-64.
262. Yan S, Zhu J, Wang Z, Yin J, Zheng Y, Chen X. Layer-by-layer assembly of poly(l-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil. Eur J Pharm Biopharm 2011;78:336-45.
263. Yang J, Park S-B, Yoon H-G, Huh Y-M, Haam S. Preparation of poly e{open}-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006;324:185-90.
264. Yang Z, Birkenhauer P, Julmy F, Chickering D, Ranieri JP et al. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation. J Control Release 1999;60:269-77.
265. Yildiz A, John E, Özsoy Y, Araman A, Birchall JC et al. Inhaled extended-release microparticles of heparin elicit improved pulmonary pharmacodynamics against antigen-mediated airway hyper-reactivity and inflammation. J Control Release 2012;162:456-63.
266. Yoncheva K, Gómez S, Campanero MA, Gamazo C, Irache JM. Bioadhesive properties of pegylated nanoparticles. Expert Opin Drug Deliv 2005;2:205-18.
267. Yoo M-K, Kang S-K, Choi J-H, Park I-K, Na H-S et al. Targeted delivery of chitosan nanoparticles to peyer's patch using m cell-homing peptide selected by phage display technique. Biomaterials 2010;31: 7738-47.
268. Yordanov G. Influence of the preparation method on the physicochemical properties of econazole-loaded poly(butyl cyanoacrylate) colloidal nanoparticles. Colloids Surf Physicochem Eng Asp 2012;413:260-5.
269. Youm I, Murowchick JB, Youan B-BC. Entrapment and release kinetics of furosemide from pegylated nanocarriers. Colloids Surf B Biointerfaces 2012;94: 133-42.
270. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005;109:256-74.
271. Zakeri-Milani P, Loveymi BD, Jelvehgari M, Valizadeh H. The characteristics and improved intestinal permeability of vancomycin plga-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces 2013;103:174-81.
272. Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998;50:31-40.
273. Zandanel C, Vauthier C. Poly (isobutylcyanoacrylate) nanoparticles decorated with chitosan: effect of conformation of chitosan chains at the surface on complement activation properties. J Colloid Sci Biotechnol 2012;1:68-81.
274. Zhang C, Li G, Wang Y, Cui F, Zhang J, Huang Q. Preparation and characterization of 5-fluorouracilloaded plla-peg/peg nanoparticles by a novel supercritical co2 technique. Int J Pharm 2012;436:272-81.
275. Zhang F, Wu Q, Chen Z-C, Zhang M, Lin X-F. Hepatic-targeting microcapsules construction by selfassembly of bioactive galactose-branched polyelectrolyte for controlled drug release system. J Colloid Interface Sci 2008a;317:477-84.
276. Zhang F, Wu Q, Liu L-J, Chen Z-C, Lin X-F. Thermal treatment of galactose-branched polyelectrolyte microcapsules to improve drug delivery with reserved targetability. Int J Pharm 2008b;357:22-31.
277. Zhang H, Cui W, Bei J, Wang S. Preparation of poly(lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution. Polym Degrad Stab 2006;91:1929-36.
278. Zhao H, Gagnon J, Hafeli UO. Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol 2007;5:2.
279. Zheng X, Kan B, Gou M, Fu S, Zhang J et al. Preparation of mpeg-pla nanoparticle for honokiol delivery in vitro. Int J Pharm 2010;386:262-7.
280. Zhou YZ, Alany RG, Chuang V, Wen J. Optimization of plga nanoparticles formulation containing ldopa by applying the central composite design. Drug Dev Ind Pharm 2013;39:321-30.